With regard to intrinsic subtype tumors, osteopontin (OPN) was significantly higher in fluids from TN (defined as estrogen receptor (ER) and/or progesterone receptor (PgR) <10% and HER2 0, 1+, 2+ CISH-negative) compared with luminal breast cancer (defined as ER and PgR expression >10% and HER2 0, 1+, 2+ CISH-negative) (Figure 2F). This evidence concerns the gene SPP1 and breast carcinoma.